Page last updated: 2024-10-28

lidocaine and Amaurosis

lidocaine has been researched along with Amaurosis in 38 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Research Excerpts

ExcerptRelevanceReference
"This case report describes an uncommon complication (blindness) occurring after an inadvertent overdosage of a frequently used local anesthetic (lidocaine) during a regional anesthetic procedure."7.71Temporary bilateral blindness after acute lidocaine toxicity. ( Sawyer, RJ; von Schroeder, H, 2002)
"Temporary amaurosis occurred after retrobulbar injection of lidocaine in 12 cases of antiglaucoma surgery in 4 years, and 10 of the patients were of late glaucoma."7.68[Temporary amaurosis from retrobulbar lidocaine injection in late glaucoma patients]. ( Mo, XJ, 1991)
"Implantation of an IOL at the time of cataract extraction under combined systemic ketamine and peribulbar lidocaine anesthesia appeared to be well tolerated and produced significant visual improvement in pediatric patients in Nepal."3.72Pediatric cataract surgery in Nepal. ( Gurung, R; Paudyal, G; Reddy, H; Ruit, S; Tabin, G; Thakur, J; Thapa, S; Wilson, ME, 2004)
"This case report describes an uncommon complication (blindness) occurring after an inadvertent overdosage of a frequently used local anesthetic (lidocaine) during a regional anesthetic procedure."3.71Temporary bilateral blindness after acute lidocaine toxicity. ( Sawyer, RJ; von Schroeder, H, 2002)
"Temporary amaurosis occurred after retrobulbar injection of lidocaine in 12 cases of antiglaucoma surgery in 4 years, and 10 of the patients were of late glaucoma."3.68[Temporary amaurosis from retrobulbar lidocaine injection in late glaucoma patients]. ( Mo, XJ, 1991)
"A transient, ipsilateral central retinal artery occlusion and contralateral amaurosis developed following retrobulbar injection of 2% lidocaine and 0."3.67Transient central retinal artery occlusion and contralateral amaurosis after retrobulbar anesthetic injection. ( Brod, RD, 1989)
"Two well-documented cases of bilateral retinal artery and choriocapillaris occlusions with blindness following head and neck soft-tissue injection with methylprednisolone acetate in combination with lidocaine, epinephrine, or penicillin are reported."3.66Bilateral retinal artery and choriocapillaris occlusion following the injection of long-acting corticosteroid suspensions in combination with other drugs: I. Clinical studies. ( Havener, WH; McGrew, RN; Wilson, RS, 1978)
"Intraoperative amaurosis was determined as that a patient could not see any light from their operative eye."1.56Correlation between sub-Tenon's anesthesia and transient amaurosis during ophthalmic surgery. ( Chen, H; Chen, W; Huang, D; Huang, Z; Lin, G; Shi, Y; Wang, Y; Zhang, G; Zhang, Q; Zheng, D, 2020)
"The occurrence of amaurosis during ophthalmic anesthesia is well known."1.46Change in flash visual evoked potentials in New Zealand albino rabbits after sub-tenon's anesthesia. ( Brelen, M; Chen, H; Chen, W; Jhanji, V; Lin, H; Wu, X; Zhang, G, 2017)
"Our report describes a case of temporary bilateral blindness in a patient after undergoing mitral valve replacement with a mechanical prosthesis and coronary artery bypass grafting."1.37Transient bilateral blindness in a patient after cardiac surgery. ( Bolman, RM; Dibardino, DJ; Tchantchaleishvili, V, 2011)
"We report a case of transient blindness, part of a TURP syndrome, in a 65 year old man undergoing TUR of the prostate under centro-neuron block."1.30Loss of vision: a manifestation of TURP syndrome. A case report. ( Bakhameez, HS; Khalaf, MM; Khan, RK; Khan-Ghori, SN, 1998)

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-199013 (34.21)18.7374
1990's5 (13.16)18.2507
2000's8 (21.05)29.6817
2010's11 (28.95)24.3611
2020's1 (2.63)2.80

Authors

AuthorsStudies
Shi, Y1
Huang, Z2
Chen, W3
Zhang, G3
Huang, D2
Lin, G2
Wang, Y1
Chen, H2
Zheng, D2
Zhang, Q1
Lartey, S1
Armah, P1
Ampong, A1
Wu, X1
Jhanji, V1
Lin, H1
Brelen, M1
Matharu, KS1
Smith, SV1
Lee, AG1
Chia, K1
Teoh, S1
Falzon, K1
Guerin, MB1
Fulcher, T1
Al-Sandook, T1
Al-Saraj, A1
Cho, HK1
Jee, D1
Lee, WK1
Shin, CH1
Ryu, JW1
Çok, OY1
Eker, HE1
Cantürk, S1
Yaycioğlu, R1
Ariboğan, A1
Arslan, G1
Tchantchaleishvili, V1
Dibardino, DJ1
Bolman, RM1
Tasi, WC1
Petersen-Jones, SM1
Huang, PY1
Lin, CT1
Bektas, D1
Kul, N1
Akyol, N1
Ural, A1
Caylan, R1
Ahmad, KE1
McColl, DC1
Duncan, M1
Lueck, CJ1
Lake, D1
Mearza, A1
Ionides, A1
Thakur, J1
Reddy, H1
Wilson, ME1
Paudyal, G1
Gurung, R1
Thapa, S1
Tabin, G1
Ruit, S1
Björkman, A1
Rosén, B1
Lundborg, G1
Bricknell, PP1
Middleton, HG1
Hollingsworth, A1
Evans, EM1
Plate, S1
Asboe, S1
Goldenberg, AS1
Hamel, P1
Boghen, D1
Khan-Ghori, SN1
Khalaf, MM1
Khan, RK1
Bakhameez, HS1
Mitchell, SJ1
Benson, M1
Vadlamudi, L1
Miller, P1
Maaranen, TH1
Mäntyjärvi, MI1
Sawyer, RJ1
von Schroeder, H1
Wilson, RS1
Havener, WH1
McGrew, RN1
Mo, XJ1
Verma, L1
Arora, R1
Kumar, A1
Rettinger, G1
Christ, P1
Brod, RD1
Nandrup, E1
Kambic, V1
Kolar, C1
Krasecec, J1
Judit, BS1
Gahlaut, DS1
Sikka, KK1
Olurin, O1
Ellis, PP1
Hanisch, J1
Födö, V1
Krüger, KE1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Lidocaine For Neuroprotection During Cardiac Surgery[NCT00938964]550 participants (Actual)Interventional2009-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Center for Epidemiological Studies Depression Scale (CES-D)

"Center for Epidemiological Studies Depression Scale (CES-D). The CES-D is a 20-item self-report examination designed to measure symptoms of depression. Subjects rate the degree to which they have experienced a range of symptoms of depression, such as I had crying spells and I felt lonely. Scores range from 0 to 60, with higher scores indicating greater depressive symptoms. Scores greater than 16 are typically considered indicative of clinically significant depression." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-1.27
Placebo-0.89

Change in Center for Epidemiological Studies Depression Scale (CES-D)

"Center for Epidemiological Studies Depression Scale (CES-D). The CES-D is a 20-item self-report examination designed to measure symptoms of depression. Subjects rate the degree to which they have experienced a range of symptoms of depression, such as I had crying spells and I felt lonely. Scores range from 0 to 60, with higher scores indicating greater depressive symptoms. Scores greater than 16 are typically considered indicative of clinically significant depression." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine0.57
Placebo0.16

Change in Cognitive Function From Baseline

To characterize cognitive function over time, while minimizing potential redundancy in the cognitive measures, a factor analysis was performed on the 14 cognitive test scores from baseline. We chose a five-factor solution, which represents 5 cognitive domains: structured verbal memory, unstructured verbal memory, executive function, visual memory and attention/concentration. To quantify overall cognitive function, a baseline cognitive index was first calculated as the mean of the 5 preoperative domain scores. The cognitive index score has a mean of zero, thus any positive score is above the mean, any negative score is below the mean. A continuous change score was then calculated by subtracting the baseline from the 1 year cognitive index. The resulting outcome measure is unbounded with standard deviation of 0.35. A negative change score indicating decline and a positive score indicating improvement (NCT00938964)
Timeframe: 1 year after surgery

Interventionunits on a scale (Mean)
Lidocaine0.09
Placebo0.07

Change in Cognitive Function From Baseline Characterized as Continuous Cognitive Change

To characterize cognitive function over time, while minimizing potential redundancy in the cognitive measures, a factor analysis was performed on the 14 cognitive test scores from baseline. We chose a five-factor solution, which represents 5 cognitive domains: structured verbal memory, unstructured verbal memory, executive function, visual memory and attention/concentration. To quantify overall cognitive function, a baseline cognitive index was first calculated as the mean of the 5 preoperative domain scores. The cognitive index score has a mean of zero, thus any positive score is above the mean, any negative score is below the mean. A continuous change score was then calculated by subtracting the baseline from the 6-week cognitive index. The resulting outcome measure is unbounded with standard deviation of 0.35. A negative change score indicating decline and a positive score indicating improvement. (NCT00938964)
Timeframe: Preoperative to 6 weeks after surgery

Interventionunits on a scale (Mean)
Lidocaine0.07
Placebo0.07

Change in Duke Activity Status Index (DASI)

"The DASI is a 12-item scale of functional capacity that has been found to correlate well with objective measures of maximal exercise capacity. Items reflect activities of personal care, ambulation, household tasks, sexual function, and recreational activities. Activities done with no difficulty receive scores, which are weighted and summed, for a quantitative measure of functional status. Scores range from 0 to 60; a higher-weighted score indicates better function." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine6.3
Placebo6.96

Change in Duke Activity Status Index (DASI)

"The DASI is a 12-item scale of functional capacity that has been found to correlate well with objective measures of maximal exercise capacity. Items reflect activities of personal care, ambulation, household tasks, sexual function, and recreational activities. Activities done with no difficulty receive scores, which are weighted and summed, for a quantitative measure of functional status. Scores range from 0 to 60; a higher-weighted score indicates better function." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine-10.98
Placebo-11.67

Change in Neurological Function, as Measured by the National Institutes of Health Stroke Scale (NIHSS)

The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. A trained observer rates the patent's ability to answer questions and perform activities. Ratings for each item are scored with 3 to 5 grades with 0 as normal, and there is an allowance for untestable items. The range of scores is from 0 (normal) to 42 (profound effect of stroke on patient). (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine0.05
Placebo0.07

Change in Neurological Function, as Measured by the National Institutes of Health Stroke Scale (NIHSS)

The National Institutes of Health Stroke Scale (NIHSS) is a 15-item neurologic examination stroke scale used to evaluate the effect of acute cerebral infarction on the levels of consciousness, language, neglect, visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and sensory loss. A trained observer rates the patent's ability to answer questions and perform activities. Ratings for each item are scored with 3 to 5 grades with 0 as normal, and there is an allowance for untestable items. The range of scores is from 0 (normal) to 42 (profound effect of stroke on patient). (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine0.05
Placebo0.04

Change in Neurological Function, as Measured by the Western Perioperative Neurologic Scale (WPNS)

The Western perioperative neurologic scale was designed to detect neurologic deficits after cardiac surgery. It includes 14 items classified into eight domains (mentation, speech, cranial nerve function, motor weakness, sensation and cerebellum, reflexes, and gait). Each item is scored from 0 (severe deficit) to3 (normal), and a maximum score of 42 indicates normal neurological function. (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine0.02
Placebo-0.02

Change in Neurological Function, as Measured by the Western Perioperative Neurologic Scale (WPNS)

The Western perioperative neurologic scale was designed to detect neurologic deficits after cardiac surgery. It includes 14 items classified into eight domains (mentation, speech, cranial nerve function, motor weakness, sensation and cerebellum, reflexes, and gait). Each item is scored from 0 (severe deficit) to3 (normal), and a maximum score of 42 indicates normal neurological function. (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine0.04
Placebo-0.01

Change in Perceived Social Support

"Perceived Social Support Scale: Twelve items indicate how strongly subjects agree that there is a special person who is around when I am in need and my family really tries to help me. Choices range from very strongly disagree to very strongly agree. Items are summed for a range of 12 to 84, with a high score meaning more social support." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine0.71
Placebo-1.16

Change in Perceived Social Support

"Perceived Social Support Scale: Twelve items indicate how strongly subjects agree that there is a special person who is around when I am in need and my family really tries to help me. Choices range from very strongly disagree to very strongly agree. Items are summed for a range of 12 to 84, with a high score meaning more social support." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine1.23
Placebo-0.49

Change in Social Activity

"Social Activity: This measure consisted of eight items that indicate the degree of social interaction. Sample items are How often do you talk on the telephone with friends and relatives? and How often do you attend meetings of social groups, clubs, or civic organizations? Scores range from 8 to 32. A lower score indicates more social activity." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-0.20
Placebo0.03

Change in Social Activity

"Social Activity: This measure consisted of eight items that indicate the degree of social interaction. Sample items are How often do you talk on the telephone with friends and relatives? and How often do you attend meetings of social groups, clubs, or civic organizations? Scores range from 8 to 32. A lower score indicates more social activity." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine0.95
Placebo1.59

Change in Spielberger State Anxiety Inventory (STAI)

"Spielberger State Anxiety Inventory (STAI): The STAI consists of two 20-item scales that measure anxiety. Representative items include statements such as I feel nervous and I feel worried. These items are rated on a 4-point scale, based on how well they describe the patient's current or typical mood, from not at all to very much so. Scores range from 20 to 80, with higher scores indicating greater anxiety." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-6.70
Placebo-6.39

Change in Spielberger State Anxiety Inventory (STAI)

"Spielberger State Anxiety Inventory (STAI): The STAI consists of two 20-item scales that measure anxiety. Representative items include statements such as I feel nervous and I feel worried. These items are rated on a 4-point scale, based on how well they describe the patient's current or typical mood, from not at all to very much so. Scores range from 20 to 80, with higher scores indicating greater anxiety." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine-7.12
Placebo-6.31

Change in Symptom Limitations

Symptom limitations: Patients were given a list of eight symptoms and asked to rate the degree to which the symptom limited daily activities. The symptoms were angina, shortness of breath, arthritis, back trouble, leg pains, headaches, fatigue, and other. Scores range from 8 to 32, with higher scores indicating greater limitations. (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-1.39
Placebo-1.48

Change in Symptom Limitations

Symptom limitations: Patients were given a list of eight symptoms and asked to rate the degree to which the symptom limited daily activities. The symptoms were angina, shortness of breath, arthritis, back trouble, leg pains, headaches, fatigue, and other. Scores range from 8 to 32, with higher scores indicating greater limitations. (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine-0.67
Placebo-0.8

Change in the Cognitive Difficulties Scale

"Cognitive Difficulties Scale: a 39-item scale, is a self-report assessment of perceived problems in long- and short-term memory, concentration, attention, and psycho-motor coordination. Sample items are I forget errands I planned to do and I fail to recognize people I know. Scores range from 39 to 164, with higher scores indicating greater cognitive difficulty." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-0.46
Placebo-1.02

Change in the Cognitive Difficulties Scale

"Cognitive Difficulties Scale: a 39-item scale, is a self-report assessment of perceived problems in long- and short-term memory, concentration, attention, and psycho-motor coordination. Sample items are I forget errands I planned to do and I fail to recognize people I know. Scores range from 39 to 164, with higher scores indicating greater cognitive difficulty." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine-3
Placebo-3.21

Change in the Duke Older Americans Resources and Services Procedures- Instrumental Activities of Daily Living (OARS-IADL)

"Duke Older Americans Resources and Services Procedures- Instrumental Activities of Daily Living (OARS-IADL): This measure contains six items that assess the ability to perform important tasks for daily living (e.g., Could you prepare your own meals? Could you drive a car?). Scores range from 6 to 24. Higher scores indicate increasing difficulty in engaging in daily activities." (NCT00938964)
Timeframe: baseline, 1-year

Interventionunits on a scale (Mean)
Lidocaine-0.15
Placebo-0.31

Change in the Duke Older Americans Resources and Services Procedures- Instrumental Activities of Daily Living (OARS-IADL)

"Duke Older Americans Resources and Services Procedures- Instrumental Activities of Daily Living (OARS-IADL): This measure contains six items that assess the ability to perform important tasks for daily living (e.g., Could you prepare your own meals? Could you drive a car?). Scores range from 6 to 24. Higher scores indicate increasing difficulty in engaging in daily activities." (NCT00938964)
Timeframe: baseline, 6-weeks

Interventionunits on a scale (Mean)
Lidocaine2.46
Placebo2.1

Count of Participants With a Decline of Greater Than or Equal to One Standard Deviation in One or More of Five Cognitive Domain Scores Reported as a Dichotomous Post-operative Cognitive Deficit (POCD) Outcome

To characterize cognitive function over time, while minimizing potential redundancy in the cognitive measures, a factor analysis was performed on the 14 cognitive test scores from baseline. We chose a five-factor solution, which represents 5 cognitive domains: structured verbal memory, unstructured verbal memory, executive function, visual memory and attention/concentration. Each domain score is normally distributed with a mean of zero. A change score was calculated for each domain by subtracting the baseline from the 6-week score. A dichotomous outcome variable of post-operative cognitive deficit was defined as a decline of ≥1 standard deviation in 1 or more of the 5 domains. (NCT00938964)
Timeframe: Preoperative to 6 weeks after surgery

InterventionParticipants (Count of Participants)
Lidocaine87
Placebo83

Change in Study 36-Item Short Form Health Survey (SF-36)

The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36): The SF-36 was designed to measure general health status. Two scales were used: Work Activities (four items) and General Health (one item). For the work activities scale, the reported score was the sum of four questions, each with values ranging from 1 to 4, the total score could range from 4 to 16. A higher score on Work Activities indicates more health-related problems For the general health question, the patients ranked their health from Excellent (1) to poor (5), the scale ranged from 1 to 5 with 1 being best health and 5 being worst. A high score in General Health indicates poorer health state. (NCT00938964)
Timeframe: baseline, 1-year

,
Interventionunits on a scale (Mean)
1 year Change Work Activities1 year Change General health perception
Lidocaine-1.37-0.28
Placebo-1.42-0.43

Change in Study 36-Item Short Form Health Survey (SF-36)

The Medical Outcomes Study 36-Item Short Form Health Survey (SF-36): The SF-36 was designed to measure general health status. Two scales were used: Work Activities (four items) and General Health (one item). For the work activities scale, the reported score was the sum of four questions, each with values ranging from 1 to 4, the total score could range from 4 to 16. A higher score on Work Activities indicates more health-related problems For the general health question, the patients ranked their health from Excellent (1) to poor (5), the scale ranged from 1 to 5 with 1 being best health and 5 being worst. A high score in General Health indicates poorer health state. (NCT00938964)
Timeframe: baseline, 6-weeks

,
Interventionunits on a scale (Mean)
6-Week Change Work activities6-Week Change General health perception
Lidocaine2.71-0.004
Placebo3-0.03

Transcerebral Activation Gradient of Platelet-neutrophil Conjugates

Paired jugular venous and radial arterial blood samples were drawn at baseline, cross-clamp removal, end of cardiopulmonary bypass, and 6 hours post cross-clamp removalime points and analyzed by fluorescence-activated cell sorting to identify activated platelets. Transcerebral activation gradients were calculated by subtracting arterial values from venous values and were compared between groups (NCT00938964)
Timeframe: Baseline to 6 hours post cross-clamp removal

,
InterventionMean linear fluorescence intensity-MLFI (Mean)
BaselineCross-clamp removalEnd of Bypass6 hours post cross-clamp removal
Lidocaine-0.150.02-0.73-0.10
Placebo-0.43-0.73-0.400.19

Transcerebral Activation Gradients of Monocytes

Paired jugular venous and radial arterial blood samples were drawn at baseline, cross-clamp removal, end of cardiopulmonary bypass, and 6 hours post cross-clamp removalime points and analyzed by fluorescence-activated cell sorting to identify activated platelets. Transcerebral activation gradients were calculated by subtracting arterial values from venous values and were compared between groups (NCT00938964)
Timeframe: Baseline to 6 hours post cross-clamp removal

,
InterventionMean linear fluorescence intensity-MLFI (Mean)
BaselineCross-clamp removalEnd of Bypass6 hours post cross-clamp removal
Lidocaine-4.22-2.46-0.341.21
Placebo-0.041.832.640.54

Transcerebral Activation Gradients of Neutrophils

Paired jugular venous and radial arterial blood samples were drawn at baseline, cross-clamp removal, end of cardiopulmonary bypass, and 6 hours post cross-clamp removal and analyzed by fluorescence-activated cell sorting to identify activated platelets. Transcerebral activation gradients were calculated by subtracting arterial values from venous values and were compared between groups (NCT00938964)
Timeframe: Baseline to 6 hours post cross-clamp removal

,
InterventionMean linear fluorescence intensity-MLFI (Mean)
BaselineCross-clamp removalEnd of Bypass6 hours post cross-clamp removal
Lidocaine-2.020.560.581.04
Placebo-0.080.171.19-0.68

Transcerebral Activation Gradients of Platelets

Paired jugular venous and radial arterial blood samples were drawn at baseline, cross-clamp removal, end of cardiopulmonary bypass, and 6 hours post cross-clamp removalime points and analyzed by fluorescence-activated cell sorting to identify activated platelets. Transcerebral activation gradients were calculated by subtracting arterial values from venous values and were compared between groups (NCT00938964)
Timeframe: Baseline to 6 hours post cross-clamp removal

,
InterventionMean linear fluorescence intensity-MLFI (Mean)
BaselineCross-clamp removalEnd of Bypass6 hours post cross-clamp removal
Lidocaine-0.030.030.330.37
Placebo0.350.430.050.27

Other Studies

38 other studies available for lidocaine and Amaurosis

ArticleYear
Correlation between sub-Tenon's anesthesia and transient amaurosis during ophthalmic surgery.
    International ophthalmology, 2020, Volume: 40, Issue:8

    Topics: Anesthesia, Local; Anesthetics, Local; Blindness; Humans; Lidocaine; Phacoemulsification; Prospectiv

2020
Incidence and impact factors of intraoperative loss of light perception under sub-Tenon's anesthesia in patients with macular diseases.
    Eye (London, England), 2019, Volume: 33, Issue:11

    Topics: Aged; Anesthesia, Local; Anesthetics, Combined; Anesthetics, Local; Blindness; Bupivacaine; Epiretin

2019
A sudden total loss of vision after routine cataract surgery.
    Ghana medical journal, 2013, Volume: 47, Issue:2

    Topics: Anesthesia, Local; Anti-Bacterial Agents; Blindness; Cataract; Cataract Extraction; Epinephrine; Fem

2013
Change in flash visual evoked potentials in New Zealand albino rabbits after sub-tenon's anesthesia.
    Cutaneous and ocular toxicology, 2017, Volume: 36, Issue:2

    Topics: Anesthesia, Local; Anesthetics, Local; Animals; Blindness; Bupivacaine; Evoked Potentials, Visual; F

2017
Retrobulbar hemorrhage and prasugrel.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2016, Volume: 51, Issue:6

    Topics: Anesthetics, Local; Blindness; Diabetic Retinopathy; Eye Pain; Female; Humans; Laser Coagulation; Li

2016
Transient amaurosis with intracameral lidocaine.
    Eye (London, England), 2009, Volume: 23, Issue:6

    Topics: Anesthetics, Local; Blindness; Humans; Injections, Intraocular; Iridectomy; Lidocaine; Male

2009
Transient, complete loss of vision secondary to posterior diffusion of an ophthalmic viscosurgical device-lidocaine solution during complicated phacoemulsification.
    Journal of cataract and refractive surgery, 2009, Volume: 35, Issue:8

    Topics: Aged; Anesthetics, Local; Blindness; Diffusion; Female; Humans; Hyaluronic Acid; Intraoperative Comp

2009
Ocular complications after inferior alveolar nerve block: a case report.
    Journal of the California Dental Association, 2010, Volume: 38, Issue:1

    Topics: Adult; Anesthesia, Dental; Anesthetics, Local; Blindness; Confusion; Diplopia; Dizziness; Female; Hu

2010
Purtscher-like retinopathy after retrobulbar anaesthesia in a patient with an intracanal mass.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2010, Volume: 45, Issue:5

    Topics: Adult; Anesthesia, Local; Anesthetics, Local; Blindness; Cataract Extraction; Evoked Potentials, Vis

2010
Pain management in blind, painful eyes: clinical experience with retrobulbar alcohol injection in 4 cases.
    Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology, 2011, Volume: 23, Issue:1

    Topics: Aged; Aged, 80 and over; Anesthetics, Local; Blindness; Ethanol; Eye Pain; Female; Glaucoma, Neovasc

2011
Transient bilateral blindness in a patient after cardiac surgery.
    The heart surgery forum, 2011, Volume: 14, Issue:3

    Topics: Anesthetics, Local; Blindness; Cardiac Surgical Procedures; Humans; Lidocaine; Male; Middle Aged

2011
The neuroprotective effects of lidocaine and methylprednisolone in a rat model of retinal ischemia-reperfusion injury.
    The Journal of veterinary medical science, 2012, Volume: 74, Issue:3

    Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents; Blindness; Electroretinography; Intraocular P

2012
Temporary blindness and ophthalmoplegia due to local anesthetic infiltration of the nasal septum.
    Ear, nose, & throat journal, 2012, Volume: 91, Issue:6

    Topics: Adult; Anesthetics, Local; Blindness; Humans; Lidocaine; Male; Nasal Septum; Ophthalmoplegia

2012
Neurological picture: bilateral optic neuropathy following unilateral retrobulbar anaesthesia: a case report.
    Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:4

    Topics: Aged, 80 and over; Amides; Anesthesia, Spinal; Anesthetics, Local; Blindness; Cataract Extraction; H

2013
Consequence of perforation during peribulbar anesthesia in an only eye.
    Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:11

    Topics: Aged; Anesthesia, Local; Anesthetics, Combined; Anesthetics, Local; Blindness; Bupivacaine; Eye Inju

2003
Pediatric cataract surgery in Nepal.
    Journal of cataract and refractive surgery, 2004, Volume: 30, Issue:8

    Topics: Adolescent; Anesthesia, General; Anesthetics, Dissociative; Anesthetics, Local; Blindness; Cataract;

2004
Recovery of nerve injury-induced alexia for Braille using forearm anaesthesia.
    Neuroreport, 2008, Apr-16, Volume: 19, Issue:6

    Topics: Aged; Anesthetics, Local; Blindness; Brachial Plexus; Dyslexia; Forearm; Hand; Humans; Lidocaine; Li

2008
Stellate ganglion block in treatment of total blindness due to quinine.
    British medical journal, 1967, Nov-18, Volume: 4, Issue:5576

    Topics: Abortion, Criminal; Adolescent; Autonomic Nerve Block; Blindness; Epinephrine; Female; Fundus Oculi;

1967
Blindness as a complication of rhinosurgery.
    The Journal of laryngology and otology, 1981, Volume: 95, Issue:3

    Topics: Adult; Blindness; Female; Humans; Lidocaine; Male; Middle Aged; Nasal Septum; Norepinephrine; Ophtha

1981
Transient diplopia as a result of block injections. Mandibular and posterior superior alveolar.
    The New York state dental journal, 1997, Volume: 63, Issue:5

    Topics: Adult; Anesthesia, Dental; Anesthetics, Local; Blindness; Diplopia; Dizziness; Female; Humans; Lidoc

1997
Bilateral amaurosis following peribulbar anesthesia.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1998, Volume: 33, Issue:4

    Topics: Aged; Anesthesia, Local; Anesthetics, Combined; Anesthetics, Local; Blindness; Bupivacaine; Glaucoma

1998
Loss of vision: a manifestation of TURP syndrome. A case report.
    Middle East journal of anaesthesiology, 1998, Volume: 14, Issue:6

    Topics: Aged; Anesthesia, Spinal; Anesthetics, Local; Blindness; Glycine; Humans; Hypotonic Solutions; Lidoc

1998
Cerebral arterial gas embolism by helium: an unusual case successfully treated with hyperbaric oxygen and lidocaine.
    Annals of emergency medicine, 2000, Volume: 35, Issue:3

    Topics: Adult; Anti-Arrhythmia Agents; Blindness; Cerebral Arteries; Embolism, Air; Helium; Humans; Hyperbar

2000
Central retinal artery occlusion after a local anesthetic with adrenaline on nasal mucosa.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2000, Volume: 20, Issue:4

    Topics: Acute Disease; Aged; Anesthetics, Local; Blindness; Drug Combinations; Epinephrine; Humans; Lacrimal

2000
Temporary bilateral blindness after acute lidocaine toxicity.
    Anesthesia and analgesia, 2002, Volume: 95, Issue:1

    Topics: Acute Disease; Adult; Anesthetics, Local; Blindness; Female; Fractures, Bone; GABA Modulators; Hand

2002
Bilateral retinal artery and choriocapillaris occlusion following the injection of long-acting corticosteroid suspensions in combination with other drugs: I. Clinical studies.
    Ophthalmology, 1978, Volume: 85, Issue:9

    Topics: Adult; Anesthesia, General; Blindness; Capillaries; Choroid; Delayed-Action Preparations; Embolism;

1978
[Temporary amaurosis from retrobulbar lidocaine injection in late glaucoma patients].
    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology, 1991, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia, Local; Blindness; Female; Glaucoma, Angle-Cl

1991
Temporary conduction block of optic nerve after retrobulbar anesthesia.
    Ophthalmic surgery, 1990, Volume: 21, Issue:2

    Topics: Adult; Blindness; Evoked Potentials, Visual; Female; Humans; Lidocaine; Male; Middle Aged; Neural Co

1990
Visual loss following intranasal injection.
    Rhinology. Supplement, 1989, Volume: 9

    Topics: Adult; Anesthesia, Local; Blindness; Humans; Injections, Subcutaneous; Lidocaine; Male; Nose Disease

1989
Transient central retinal artery occlusion and contralateral amaurosis after retrobulbar anesthetic injection.
    Ophthalmic surgery, 1989, Volume: 20, Issue:9

    Topics: Aged; Anesthesia, Local; Blindness; Bupivacaine; Female; Humans; Injections; Lidocaine; Optic Nerve

1989
Visual acuity increased by stellate ganglion block. Case reports.
    Acta ophthalmologica, 1987, Volume: 65, Issue:1

    Topics: Aged; Autonomic Nerve Block; Blindness; Female; Humans; Lidocaine; Macular Degeneration; Male; Middl

1987
[Unilateral permanet brutal loss of the vision after an endonasal submucous injection of an anesthetic compound].
    Journal francais d'oto-rhino-laryngologie, audio-phonologie et chirurgie maxillo-faciale, 1968, Volume: 17, Issue:1

    Topics: Adult; Anesthetics; Blindness; Humans; Injections; Lidocaine; Male; Tetracaine

1968
[Iatrogenic lesion in ophthalmologic anesthesia].
    Klinische Monatsblatter fur Augenheilkunde, 1972, Volume: 161, Issue:3

    Topics: Adult; Aged; Anesthesia, General; Anesthesia, Local; Anesthetics; Anesthetics, Local; Atropine; Blin

1972
Transient neurological complications following mandibular nerve block.
    Journal of the Indian Medical Association, 1972, Feb-01, Volume: 58, Issue:3

    Topics: Abducens Nerve; Adult; Anesthesia, Dental; Anesthesia, Local; Blindness; Facial Paralysis; Humans; L

1972
Cortical blindness following convulsions and fever in Nigerian children.
    Pediatrics, 1970, Volume: 46, Issue:1

    Topics: Anti-Bacterial Agents; Anticonvulsants; Blindness; Blood Transfusion; Bronchopneumonia; Cerebral Cor

1970
Visual loss following tonsillectomy; possible association with injections in tonsillar fossae.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1968, Volume: 87, Issue:4

    Topics: Blindness; Carotid Arteries; Child; Humans; Injections; Lidocaine; Male; Methylprednisolone; Penicil

1968
[On trsnsitory amauroses in retrobulbar and stomatologic local antsthesia].
    Klinische Monatsblatter fur Augenheilkunde, 1968, Volume: 153, Issue:2

    Topics: Adult; Aged; Anesthesia, Dental; Anesthesia, Local; Blindness; Female; Glaucoma; Humans; Lidocaine;

1968
[Temporary blindness following retrobulbar anesthesia].
    Klinische Monatsblatter fur Augenheilkunde, 1966, Volume: 149, Issue:4

    Topics: Adult; Anesthesia, Local; Blindness; Humans; Hyaluronoglucosaminidase; Lidocaine; Male; Nystagmus, P

1966